Haixiang Pharmaceutical: Announcement on providing guarantee lines for subsidiaries within the scope of consolidated statements
Securities code: 002099 Securities abbreviation: Haixiang Pharmaceutical Announcement number: 2026-023
Zhejiang Haixiang Pharmaceutical Co., Ltd.
Announcement on providing guarantee lines for subsidiaries within the scope of consolidated statements
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
The second meeting of the eighth board of directors of Zhejiang Haixiang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") reviewed and approved the "Proposal on Providing Guarantee Lines for Subsidiaries within the Scope of Consolidated Statements." The specific situation is announced as follows:
1. Overview of guarantee situation
In order to meet the operation and development needs of subsidiaries within the scope of consolidated statements, the company plans to provide a guarantee line for subsidiaries within the scope of consolidated statements, with a total guarantee of 905 million yuan (or equivalent foreign currency), of which subsidiaries within the scope of consolidated statements with an asset-liability ratio of less than 70% Provide a total guarantee line of 455 million yuan (or equivalent foreign currency) for subsidiaries within the scope of consolidated statements with an asset-liability ratio higher than 70%. The actual guarantee amount shall be subject to the officially signed guarantee agreement. The scope of this guarantee includes but is not limited to applying for comprehensive credit, borrowing, financial leasing and other financing or carrying out other daily business operations; the types of guarantees include guarantees, mortgages, pledges, etc.; the guarantee methods include direct guarantees or providing counter guarantees.
According to relevant regulations such as the "Shenzhen Stock Exchange Stock Listing Rules" and "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations of Main Board Listed Companies", this matter still needs to be submitted to the company's shareholders' meeting for review and approval before it will take effect. The guarantee limit is valid from the date of review and approval by the 2025 annual shareholders' meeting to the date of the 2026 annual shareholders' meeting. In order to improve work efficiency, the shareholders' meeting is requested to authorize the general manager of the company to make decisions on specific matters within the above quota and time limit and sign relevant documents.
2. Estimated guarantee amount
Unit: Guarantee limit of RMB 10,000 per share
The guaranteed party’s maximum period is as of 2026
Guaranteed party's shareholding Estimated total guaranteed amount Listed company's maximum number of related guaranteeing parties Secured party's most recent assets Guaranteed on March 31
Ratio Quota Net equity in the latest period Guaranteed liability ratio Guaranteed balance
Production ratio
Zhejiang Haixiang Zhejiang Haixiang 100% 52.64% 6,030 12,500 2.48% No Pharmaceutical Shares Sichuan Nan Pharmaceutical
Ltd. Ltd.
In front of Taizhou City
Evolution Engineering has 100% 37.16% 0 10,000 1.99% No limited company
Taizhou City Zhen
Hong Kong Dye Chemical
100% 38.00% 0 8,000 1.59% No Labor Co., Ltd.
Division
Taizhou Dongyao
Trading Co., Ltd. 100% 46.75% 0 10,000 1.99% No company
Zhejiang Qilian
Environmental protection technology 100% 23.98% 0 5,000 0.99% No limited company
Total subsidiaries with asset-liability ratio below 70% 6,030 45,500 9.04% -Zhejiang Mingxiang
Pharmaceutical Co., Ltd. 100% 91.17% 0 5,000 0.99% No company
Taizhou City East
Asahi Medical Chemical Equipment
100% 108.85% 0 2,000 0.40% No limited liability company
Division
Zhejiang Gangxiang
Trading Co., Ltd. 100% 127.63% 0 1,000 0.20% No company
Hong Kong International
Holding(Hong Kong)
100% 98.10% 186.81 20,000 3.98% Hong Kong) Co., Ltd.
Division
Taizhou Jinfeng
Pharmaceutical and chemical industry 100% 88.83% 179.09 10,000 1.99% No limited company
Yichang Haixiang
Pharmaceutical Co., Ltd. 100% 105.23% 0 5,000 0.99% No company
Yichang Haixiang
Medical and chemical equipment 100% 106.54% 0 2,000 0.40% No limited company
Total of subsidiaries with asset-liability ratio above 70% 365.90 45,000 8.95% -
Total 6,395.90 90,500 17.99% - For guarantee matters that occur within the above approved quota, the guarantee limit can be adjusted between subsidiaries within the scope of the consolidated statement; when the adjustment occurs, the guarantee limit can be adjusted between subsidiaries with an asset-liability ratio of no more than 70%, and the guarantee limit can be adjusted between subsidiaries with an asset-liability ratio of more than 70%. The guarantee limit cannot be adjusted between companies with an asset-liability ratio of more than 70% and no more than 70%.
3. Basic information of the guaranteed person
Unit: RMB 10,000
Is it related to our company?
Serial number Guaranteed unit Registered capital Business scope Suspended for breach of trust
Executor
Veterinary drug manufacturing, API manufacturing, chemical product recycling, chemical raw materials and Zhejiang Haixiangchuan
Scope of consolidated statements Manufacturing of products (excluding hazardous chemicals and precursor chemicals), pharmaceutical waste 1 Nan Pharmaceutical Co., Ltd. 64,000 No scope of subsidiaries Collection, storage, and incineration of hazardous wastes such as pharmaceuticals, waste medicines, and pharmaceuticals
Location, import and export of goods.
Taizhou City Advance
Scope of consolidated statements Manufacturing and sales of dyes, dye intermediates and bromide salts; import and export of goods and technology 2 Chemical Co., Ltd. 30,400 No within-scope subsidiary.
Division
Taizhou Zhengang General projects: production of chemical products (excluding licensed chemical products); scope of consolidated statements
3 Dye Chemical has 6,000 chemical products sold (excluding licensed chemical products). Licensed projects: No subsidiaries within the scope
Co., Ltd. Goods import and export; Technology import and export.
Licensed items: pharmaceutical production; pharmaceutical commissioned production; veterinary drug production; veterinary drug business. General items: technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; sales of machinery and equipment; wholesale of electronic components; sales of household appliances; retail of daily household appliances; sales of electrical appliances Zhejiang Mingxiang Pharmaceutical Consolidated Statements Scope of auxiliary parts; wholesale of hardware products; sales of building materials; lightweight construction 4 5,000 No Industry Co., Ltd. Within-scope subsidiary Sales of materials; sales of furniture spare parts; sales of furniture; sales of glass instruments; sales of daily glass products; sales of electronic products; sales of experimental analysis instruments; sales of intelligent instruments; sales of instruments; wholesale of clothing; sales of daily necessities; sales of chemical products (excluding licensed products)
chemical products).
General projects: technical services, technology development, technical consulting, technology exchange, technology transfer, technology promotion; sewage treatment and recycling; scope of consolidated statements
5 Bao Technology Co., Ltd. 10,000 Heat production and supply; business management; sales of special equipment for environmental protection; no subsidiaries
The company sells chemical products (excluding licensed chemical products). Licensed items:
Hazardous waste operations.
Taizhou Dongxu
The scope of the consolidated statements includes manufacturing, processing and sales of special equipment for chemical production, special equipment and spare parts for pharmaceuticals, pressure vessels and spare parts; installation of pipeline equipment. Ltd.
General items: sales of machinery and equipment; wholesale of electronic components; sales of power electronic components; retail of electronic components; sales of household appliances; Zhejiang Port Consolidated Statement Scope Sales of electrical appliances and spare parts; retail of daily household appliances; wholesale of daily necessities; daily 7 1,000 No Trade Co., Ltd. Within-scope subsidiary Sales of supplies; sales of daily necessities; wholesale of kitchenware, sanitary ware and daily sundries; Internet sales; sales of electrical accessories; sales of daily sundries; wholesale of hardware products; retail of hardware products; sales of building materials; sales of lightweight building materials; sales of furniture spare parts; sales of furniture; sales of glass instruments; sales of daily glass products; sales of mechanical and electrical equipment; sales of electrical equipment; sales of experimental analysis instruments; sales of intelligent instruments; sales of instruments; electronic measuring instruments Sales; wholesale of clothing and apparel; retail of clothing and apparel; sales of clothing accessories; wholesale of stationery; retail of stationery; sales of office supplies; sales of office equipment; sales of office equipment consumables; sales of labor protection supplies; sales of special labor protection supplies; sales of arts and crafts and ceremonial supplies; wholesale of shoes and hats; retail of shoes and hats; wholesale of computer software, hardware and auxiliary equipment; retail of computer software, hardware and auxiliary equipment; sales of industrial control computers and systems; sales of calculator equipment
for sale.
Hong Kong Xiang International Holdings
Consolidated statement template
8 shares (Hong Kong) with HKD 10,000 Chemical trading No subsidiary within scope
Ltd.
General projects: chemical product production (excluding licensed chemical products); Taizhou Jinfeng Medical
Scope of consolidated statements: sales of chemical products (excluding licensed chemical products); import and export of goods; 9 Pharmaceutical Chemical Co., Ltd. 5,000 No subsidiaries within the scope: technology import and export. Licensed projects: veterinary drug production; pharmaceutical production; pharmaceutical companies
Commissioned production.
General items: sales of chemical products (excluding licensed chemical products); Taizhou Dongyaoshang Consolidated Statements
10 500 Sales of electronic products; sales of coal and products; sales of metal materials; subsidiaries within the scope of Jianfu Trading Co., Ltd.
Sales of building materials; sales of metal structures; sales of building decoration materials. Licensed items: pharmaceutical production; pharmaceutical commissioned production; pharmaceutical import and export. Yichang Haixiang Pharmaceutical Consolidated statement scope General items: technology import and export; goods import and export; basic chemical raw materials 11 10,000 Fuye Co., Ltd. Within-scope subsidiary manufacturing (excluding the manufacturing of hazardous chemicals and other licensed chemicals); chemicals
Production of industrial products (excluding licensed chemical products).
Licensed items: Special equipment manufacturing. General projects: general equipment manufacturing (excluding special equipment manufacturing); mechanical equipment research and development; mechanical equipment sales; industrial control computers and system manufacturing; industrial control computers and consolidated statements
12 Chemical Equipment Co., Ltd. 1,000 System sales; Intelligent basic manufacturing equipment manufacturing; Intelligent basic manufacturing equipment No within-scope subsidiaries
The company prepares sales; manufactures special equipment for environmental protection; sales of special equipment for environmental protection; sales of special equipment; general mechanical equipment installation services; fire protection
Technical services.
As of December 31, 2025, the main financial data of the guaranteed party:
Unit: RMB yuan order
Guaranteed unit Total assets Total liabilities Net assets Operating income Total profits Net profit number
Zhejiang Haixiangchuan
2,349,887,5 1,237,021,2 1,112,866,2 1,178,261,5 6,179,242.3 8,094,183.7 1 Nan Pharmaceutical Co., Ltd.
36.04 61.44 74.60 85.80 8 5Company
Taizhou City Advance
2,031,282,4 754,911,705 1,276,370,7 612,716,496 39,490,583. 21,267,777. 2 Chemical Industry Co., Ltd.
76.01 .33 70.68 .99 21 50 Division
3 Taizhou Zhengang 679,405,820 258,185,548 421,220,272 317,114,722 -2,655,409. -4,462,745. Dye Chemical Co., Ltd. .61 .30 .31 .26 64 82
Zhejiang Mingxiang Pharmaceutical 267,497,417 243,872,130 23,625,286. 96,179,332.
4 697,301.40 56,672.11 Industry Co., Ltd. .11 .21 90 32
Zhejiang Qilianhuan
118,399,017 28,390,901. 90,008,115. 20,911,022. -2,640,579. -2,640,579. 5 Bao Technology Co., Ltd.
.40 84 56 21 79 79 company
Taizhou Dongxu
11,587,229. 12,612,572. -1,025,343. 4,508,184.9 -1,433,541. -1,615,450. 6 Medical and chemical equipment
50 50 00 3 44 75 Co., Ltd.
Zhejiang Gangxiang Merchant
7 948.02 1,210.00 -261.98 -126.80 -126.80 Trading Co., Ltd.
Hong Kong Xiang International Holdings
440,214,950 431,844,495 8,370,454.7 591,370,971 26,359,031. 25,300,589. 8 shares (Hong Kong) Yes
.23 .47 6 .09 58 60 Co., Ltd.
Taizhou Jinfeng Medical
691,616,565 614,359,522 77,257,042. 240,378,284 -72,293,879 -60,480,831 9 Pharmaceutical Chemical Co., Ltd.
.11 .88 23 .90 .36 .09Company
Taizhou Dongyaoshang 7,514,441.0 3,513,190.4 4,001,250.5 67,582,871.
10 492,946.82 468,299.48 Trading Co., Ltd. 3 4 9 96
Yichang Haixiang Pharmaceutical 310,405,726 326,628,883 -16,223,157 -7,118,294. -7,118,294. 11 129,964.61
Industry Co., Ltd. .39 .98 .59 34 34Yichang Haixiang Medical
154,586,966 164,695,019 -10,108,052 23,520,967. -4,554,596. -4,554,596. 12 Chemical Equipment Co., Ltd.
.50 .07 .57 84 88 88Company
4. Main contents of the guarantee agreement
This time, it is an estimate of the guarantee limit provided by the company to its subsidiaries within the scope of the consolidated statements. When actual financing and guarantees occur, the guarantee objects, guarantee amount, guarantee method, guarantee period and other contents will be determined through consultation between the company and credit banks and other financial institutions within the above guarantee limit, subject to the officially signed guarantee document. The above guarantee limit can be recycled during the guarantee period.
5. Opinions of the Board of Directors
The board of directors believes that the guarantee amount provided by the company based on the business development of subsidiaries within the scope of each consolidated statement is to meet the capital needs of its normal operating development, improve financing efficiency, ensure the smooth development of business, and is in the overall interests of the company. The amount of guarantee provided this time is in line with the overall interests of the company, does not violate laws and regulations, and does not harm the interests of the company's shareholders.
6. Cumulative number of external guarantees and number of overdue guarantees
As of the disclosure date of this announcement, the company's total guarantee line for subsidiaries within the scope of the consolidated statements is RMB 905 million, accounting for 17.99% of the company's latest audited net assets. As of March 31, 2026, the company's guarantee balance for subsidiaries within the scope of the consolidated statements was RMB 63.959 million (converted based on the exchange rate on March 31, 2026). After this guarantee was reviewed and approved by the shareholders' meeting, the company's total guarantee amount for subsidiaries within the scope of the consolidated statements was RMB 905 million, accounting for 17.99% of the company's latest audited net assets. The company does not provide guarantees to companies outside the scope of consolidated statements, and there are no overdue guarantees.
7. Documents for reference
- Resolution of the second meeting of the company’s eighth board of directors.
Announcement is hereby made.
Board of Directors of Zhejiang Haixiang Pharmaceutical Co., Ltd.
April 29, 2026